Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
| ▸ | PDE1A | P54750 | 1/20 | 0.31 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.31 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16616905 | 0.83 | ADORA2A (0.44) | KMOADORA2AADORA2BPDE1APDE1B | |
| SCHEMBL31039286 | 0.83 | EGFR (0.41) | KMOADORA2AADORA2BIDO1TDO2 | |
| SCHEMBL23994142 | 0.78 | CYP17A1 (0.43) | ADORA2AADORA2B | |
| SCHEMBL29426945 | 0.78 | IDO1 (0.43) | ADORA2AADORA2BIDO1TDO2HSD17B10 | |
| SCHEMBL25411517 | 0.78 | IDO1 (0.43) | ADORA2AADORA2BIDO1TDO2HSD17B10 | |
| SCHEMBL29035700 | 0.70 | CYP1A2 (0.35) | — | |
| SCHEMBL31039261 | 0.67 | EZH2 (0.32) | — | |
| SCHEMBL2588357 | 0.66 | KMO (0.43) | KMOADORA2AADORA2BPDE1APDE1B | |
| SCHEMBL16617143 | 0.66 | PTGER3 (0.41) | ADORA2AADORA2BPDE1APDE1BPDE1C | |
| SCHEMBL1252516 | 0.66 | ADORA2A (0.40) | KMOADORA2AADORA2BIDO1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655296-A1 | CBL-B INHIBITORS | Aurigene Oncology Limited (IN) | 2025-12-03 | — | — | EP | disclosed |
| WO-2024156938-A1 | CBL-B INHIBITORS | ORION CORPORATION (FI) | 2024-08-02 | — | — | WO | disclosed |